Chemoprophylaxis in contacts of patients with cholera: Systematic review and meta-analysis

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Reveiz, Ludovic ^a   Chapman, Evelina ^a   Ramon Pardo, Pilar ^b   Koehlmoos, Tracey Perez ^c   Cuervo, Luis Gabriel ^a   Aldighieri, Sylvain ^a   Chambliss, Amy ^d  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DOXYCYCLINE; SULFADOXINE; TETRACYCLINE; VITAMIN;

ANTIBIOTIC SENSITIVITY; CHEMOPROPHYLAXIS; CHOLERA; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FOLLOW UP; HOSPITALIZATION; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; META ANALYSIS; NAUSEA; OUTCOME ASSESSMENT; REVIEW; SYSTEMATIC REVIEW; VOMITING; META ANALYSIS (TOPIC);

CHEMOPREVENTION; CHOLERA; HUMANS; META-ANALYSIS AS TOPIC;

EID: 81255173011     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027060     Document Type: Review

References (42)

1. United Nations. The Millennium Development Goals Report (2008) New York. Available: http://mdgs.un.org/unsd/mdg/Resources/Static/Products/Progress2008/MDG_R eport_2008_En.pdf. Accessed 2010 December 9.
2. World Health Organization (2010) Available: http://www.who.int/immunization/newsroom/news_revised_position_paper_cho lera_vaccines/en/index.html Accessed: 2010 December 9.
3. Zuckerman JN, Rombo L, Fisch A, (2007) The true burden and risk of cholera: implications for prevention and control. Lancet Infectious Diseases 7 (8): 521-30.
4. World Health Organization. Weekly epidemiological record (2009) 31July 2009, 84th year. No. 31, 2009, 84, 309-24. Available: http://www.who.int/wer/2009/wer8431.pdf Accessed 2010 November 29.
5. Pan American Health Organization (2010) PAHO responds to cholera outbreak in Haiti. Available: http://new.paho.org/disasters/index.php?option=com_content&task=view &id=1423&Itemid=1 Accessed 2010 November 29.
6. CDC update cholera outbreak - Haiti (2010) MMWR Morb Mortal Weekly Report 59: 1473-79.
7. Préliminaire data Ministère de la Sante Publique et de la Population de Haïti (2011) Available: http://www.mspp.gouv.ht/site/downloads/Rapport%20journalier%20MSPP%20du% 2002%20fevrier%202011.pdf Accessed 2011 February 14.
8. World Health Organization (2010) Cholera vaccines: WHO position paper. Wkly Epidemiol Rec 85: 117-128 Available: http://www.who.int/wer/2010/wer8513.pdf Accessed 2010 December 9.
9. Global Task Force on Cholera Control. Prevention and control of cholera outbreaks: WHO policy and recommendations. Available: http://www.who.int/cholera/technical/prevention/control/en/index2.html. Accessed 2010 December 9.
10. Guévart E, Noeske J, Sollé J, Mouangue A, Bikoti JM, (2007) Large-scale selective antibiotic prophylaxis during the 2004 cholera outbreak in Douala (Cameroon). Sante 17 (2): 63-8.
11. Weil AA, Khan AI, Chowdhury F, Larocque RC, Faruque AS, et al. (2009) Clinical outcomes in household contacts of patients with cholera in Bangladesh. Clin Infect Dis 49 (10): 1473-9.
12. Higgins JPT, Green S, eds. (2009) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration. Accessed 2010 November 9.
13. Deb BC, Sen Gupta PG, De SP, Sil J, Sikdar SN, et al. (1976) Effect of sulfadoxine on transmission of Vibrio cholera infection among family contacts of cholera patients in Calcutta. Bull World Health Organ 54: 171-175.
14. Echevarría J, Seas C, Carrillo C, Mostorino R, Ruiz R, et al. (1995) Efficacy and tolerability of ciprofloxacin prophylaxis in adult household contacts of patients with cholera. Clin Infect Dis 20 (6): 1480-4.
15. Joint ICMR-GWB-WHO Cholera Study Group (1970) Serological studies on cholera patients and their household contacts in Calcutta in 1968. Joint ICMR-GWB-WHO Cholera Study Group, Calcutta, India. Bull World Health Organ 43 (3): 389-99.
16. Khan MU, (1982) Efficacy of short course antibiotic prophylaxis in controlling cholera in contacts during epidemic. J Trop Med Hyg 85 (1): 27-9.
17. Lapeyssonnie L, (1971) Chemoprophylaxis of cholera: value, expectations, and limitations. Med Trop (Mars); 31 (1): 127-32.
18. McCormack WM, Chowdhury AM, Jahangir N, Ahmed AB, Mosley WH, (1968) Tetracycline prophylaxis in families of cholera patients. Bull World Health Organ 38 (5): 787-92.
19. Sen Gupta PG, Sircar BK, Mondal S, De SP, Sen D, et al. (1978) Effect of doxycycline on transmission of Vibrio cholerae infection among family contacts of cholera patients in Calcutta. Bull World Health Organ; 56: 323-326.
20. Guévart E, Solle J, Noeske J, Amougou G, Mouangue A, et al. (2005) Mass antibiotic prophylaxis against cholera in the New Bell central prison in Douala during the 2004 epidemic. Sante 15 (4): 225-7.
21. Guévart E, Solle J, Mouangue A, Noeske J, Bita A, et al. (2006) Antibiotic susceptibility of Vibrio cholerae 01: evolution after prolonged curative and preventive use during the 2004 cholera epidemics in Douala (Cameroon). Med Mal Infect 36 (6): 329-34.
22. Gharagozloo RA, Naficy K, (1970) Comparative Trial of Tetracycline, Chloramphenicol, and Trimethoprim/Sulphamethoxazole in Eradication of Vibrio cholerae El Tor. British Medical Journal 4: 281-282.
23. Pierce NF, Banwell JG, Mitra RC, Caranasos GJ, Keimowitz RI, et al. (1968) Controlled Comparison of Tetracycline and Furazolidone in Cholera. British Medical Journal 3: 277-280.
24. Usubütün S, Aǧalar C, Diri C, Türkyilmaz R, (1997) Single dose ciprofloxacin in cholera. Eur J Emerg Med 4 (3): 145-9.
25. Islam MR, (1987) Single dose tetracycline in cholera. Gut 28: 1029-1032.
26. Sack D, Islam S, Rabbani H, Islam A, (1978) Single-Dose Doxycycline for Cholera. Antimicrobial Agents And Chemotherapy; 14 (3): 462-464.
27. Gangarosa EJ, Saghari H, Emile J, Sanati A, Siadat H, et al. (1966) Search for a mass chemotherapeutic drug for cholera control. Bull World Health Organization 35: 669-674.
28. Centers for Disease Control and Prevention (CDC) (2010) Cholera outbreak - Haiti, October 2010. MMWR Morb Mortal Wkly Rep 59 (43): 1411.
29. Ranjbar M, Rahmani E, Nooriamiri A, Gholami H, Golmohamadi A, et al. (2010) High prevalence of multidrug-resistant strains of Vibrio cholerae, in a cholera outbreak in Tehran-Iran, during June-September 2008. Trop Doct 40 (4): 214-6.
30. Manga NM, Ndour CT, Diop SA, Dia NM, Ka-Sall R, et al. (2008) Cholera in Senegal from 2004 to 2006: lessons learned from successive outbreaks. Med Trop (Mars) 68 (6): 589-92.
31. Karki R, Bhatta DR, Malla S, Dumre SP, (2010) Cholera incidence among patients with diarrhea visiting National Public Health Laboratory, Nepal. Jpn J Infect Dis 63 (3): 185-7.
32. Kingston JJ, Zachariah K, Tuteja U, Kumar S, Batra HV, (2009) Molecular characterization of Vibrio cholerae isolates from cholera outbreaks in North India. J Microbiol 47 (1): 110-5.
33. Keramat F, Hashemi SH, Mamani M, Ranjbar M, Erfan H, (2008) Survey of antibiogram tests in cholera patients in the 2005 epidemic in Hamadan, Islamic Republic of Iran. East Mediterr Health J 14 (4): 768-75.
34. Ngandjio A, Tejiokem M, Wouafo M, Ndome I, Yonga M, et al. (2009) Antimicrobial resistance and molecular characterization of Vibrio cholerae O1 during the 2004 and 2005 outbreak of cholera in Cameroon. Foodborne Pathog Dis 6 (1): 49-56.
35. Saha D, Khan WA, Karim MM, Chowdhury HR, Salam MA, et al. (2005) Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: a randomised controlled trial. Lancet 366: 1085-1093.
36. Mhalu FS, Mmari PW, Ijumba J, (1979) Rapid emergence of El Tor Vibrio cholerae resistant to antimicrobial agents during first six months of fourth cholera epidemic in Tanzania. Lancet 1: 345-347.
37. Dromigny JA, Rakoto-Alson O, Rajaonatahina D, Migliani R, Ranjalahy J, et al. (2002) Emergence and rapid spread of tetracycline-resistant Vibrio cholerae strains, Madagascar. Emerg Infect Dis 8: 336-338.
38. Towner KJ, Pearson NJ, Mhalu FS, O'Grady F, (1980) Resistance to antimicrobial agents of Vibrio cholerae E1 Tor strains isolated during the fourth cholera epidemic in the United Republic of Tanzania. Bull World Health Organ; 58 (5): 747-51.
39. Weber JT, Mintz ED, Cañizares R, Semiglia A, Gomez I, et al. (1994) Epidemic cholera in Ecuador: multidrug-resistance and transmission by water and seafood. Epidemiol Infect; 112 (1): 1-11.
40. Okuda J, Hayashi N, Wakahara Y, Gotoh N, (2010) Reduced Expression of the vca0421 Gene of Vibrio cholerae O1 Results in Innate Resistance to Ciprofloxacin. Antimicrob Agents Chemother; 54 (11): 4917-4919.
41. Ghosh A, Ramamurthy T, (2011) Antimicrobials & cholera: are we stranded? Indian J Med Res 133 (2): 225-31.
42. Schulz KF, Altman DG, Moher D, for the CONSORT Group (2010) CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Lancet 375 (9721): 1144-6.